Foreign Acquisition Of Chinese Medicine Research And Development Company Pulled The Curtain

April 26, foreign investors in China's largest pharmaceutical merger baked: the largest U.S

. drug development company?? Charles Valley Laboratories (CharlesRiverLaboratoriesInternational (NYSE: CRL), hereinafter referred to as "Charles River Valley") to 1.6 billion U.S. dollars acquisition of Wuxi, WuXi PharmaTech Co., Ltd. (NYSE: WX, hereinafter referred to as "WuXi PharmaTech.")

Charles River Valley 40 years in the last century by the founding father of JamesC.Foster, JamesC.Foster led the company last year achieved revenue of 1.2 billion, the company currently has 9,000 employees around the world. WuXi PharmaTech is a

established only 10 years, sales of 270 million U.S. dollars of pharmaceutical R & D outsourcing company. This acquisition not only means WuXi PharmaTech's drug development outsourcing, "China" model has been concerned at the same time, foreign investment enterprises in China's pharmaceutical R & D M & A curtain has quietly opened its industrial chain in the world of pharmaceutical outsourcing is more far-reaching.

Drug development star appearance and exit

WuXi PharmaTech pioneered the outsourcing of drug development, "China" model, now, this model has become a model for pharmaceutical R & D enterprise. For this model, the largest bio-pharmaceutical research and development outsourcing company Biological Technology Co., Ltd. Nanjing Jin Sirui Shi Yan Ningbo vice president explained: "To save costs, large pharmaceutical companies abroad, the drug reduced the employment of scientists, but the change WuXi PharmaTech provided by the team of China's scientific research, undertake appropriate research and development expertise. "WuXi PharmaTech to the main reason for success is the company in the domestic first carried out in strict accordance with international standards, large-scale research and development.

WuXi PharmaTech and even foreign companies according to different groups, such as Merck Group, Pfizer Group, etc., and signed with these companies for several years, outsourcing agreement. Meanwhile, the group researchers as research and development of these large companies "brain trust" at any time with these companies to open R & D conference, in accordance with the requirements of a key R & D experiment. The largest clinical research company?? By Gus Medical Technology Co., Ltd. Wei Xiong, former general manager that, the company is at least in this country to carry out large-scale "research group outsourcing" model of the first drug development company.

According to data released WuXi PharmaTech, the world's top 20 pharmaceutical companies in the 18 and the top 10 pharmaceutical companies in the nine have become the company's customers. According to WuXi PharmaTech 2009 Annual Report, revenues 270 million U.S. dollars, gross profit 108.3 million U.S. dollars.

5 6, Ge Li, the founder of WuXi PharmaTech accepted to be interviewed. Ge Li said that the acquisition of Charles River Valley WuXi PharmaTech, will WuXi PharmaTech's services from drug development to clinical trials, the most upstream development, integration, it was his expectation. By then, the new company will have sales of 1.5 billion dollars, 1.2 million employees. After the merger, Ge Li as the new executive vice president and global R & D and China, president.

Foreign investors step up action Before the acquisition of WuXi PharmaTech, China's foreign acquisition comes as the pharmaceutical industry's largest acquisition of Bayer Pharmaceuticals Dongsheng the OTC business, the matter in March 4, 2008 ended, when the two sides stated that the final Bayer invested 1.264 billion yuan to complete the acquisition. But in the decades before and since, China's large-scale foreign investment has not expressed much interest in pharmaceutical companies. In this regard, a veteran of pharmaceutical industry, large pharmaceutical companies in China actually is inadequate. Large pharmaceutical companies abroad each year can be introduced several innovative medicines, with a strong R & D capability, and China's innovative drugs (a class of drugs) every year but one or two, once vacant and even a few years ago, the lack of R & D .

Have engaged in drug development industry, Bayer (China), former general manager, Group CEO Gao Zhan good doctor that the Charles River Valley see is the pattern established by WuXi PharmaTech and Chinese low-cost human resources. If your in China and WuXi PharmaTech to establish a competing company, it would be time consuming and more risky things, the acquisition much easier.

Foreign Acquisition Of Chinese Medicine Research And Development Company Pulled The Curtain

By: frbiz2@163.com

POST COMMENT

I Want To Become A Medical Transcriptionist Helpful Info Gout Cures That Work - No Doctor'S Fees And No More Drugs New Facts Acid Reflux Medicine - Finally Key Information About Your Different Options The Availability Of Alternative Medicine Depression Treatment And Therapy Telemedicine Is Helping The Third World Harmful Drugs Harmed Consumers May Be Entitled to Compensation Purchase Florida Medical Supplies Quickly Take advantage of discounted drugs with free prescription from DiscountedDrugs.org Important Facts You Need To Know About California's Medical Marijuana Program: How To Get Your Medic Drugs and Driving on the Rise in Houston and Nationally Medical Marijuana : A Quick Guide for 2010 Why Choose Herbal Pain Relievers Over Prescribed Drugs? 5 Unfortunate Effects of Medical Malpractice